You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pembrolizumab (KEYTRUDA)

Showing 1 - 25 of 1,578
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric and Gastroesophageal Junction Adenocarcinoma Trial (Pembrolizumab (Keytruda®), Trifluridine/Tipiracil (Lonsurf®))

Not yet recruiting
  • Gastric and Gastroesophageal Junction Adenocarcinoma
  • Pembrolizumab (Keytruda®), Trifluridine/Tipiracil (Lonsurf®)
  • (no location specified)
Aug 17, 2022

Melanoma Trial (GME751, Keytruda - EU, Keytruda - US)

Not yet recruiting
  • Melanoma
  • (no location specified)
Nov 22, 2023

Profiling of Pembrolizumab and Nivolumab in Melanoma and/or

Active, not recruiting
  • Lung Non-Small Cell Carcinoma
  • Melanoma
  • Biospecimen Collection
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 13, 2023

Thyroid Cancer Trial in Palo Alto (Pembrolizumab (Keytruda))

Recruiting
  • Thyroid Cancer
  • Pembrolizumab (Keytruda)
  • Palo Alto, California
    Stanford University
Feb 16, 2022

Non Small Cell Lung Cancer Metastatic Trial (Pembrolizumab, Pembrolizumab biosimilar)

Not yet recruiting
  • Non Small Cell Lung Cancer Metastatic
  • (no location specified)
Dec 19, 2022

Melanoma (Skin) Trial in Omsk, Saint Petersburg (BCD-201, Keytruda)

Recruiting
  • Melanoma (Skin)
  • Omsk, Russian Federation
  • +2 more
Aug 1, 2023

Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer Trial run by the National Cancer Institute

Recruiting
  • Metastatic Colorectal Cancer
  • +4 more
  • Young TIL
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

GBM Trial (Lenvatinib, Pembrolizumab, Tumor Treating Fields (TTFields))

Not yet recruiting
  • GBM
  • (no location specified)
Aug 2, 2023

Healthy Male Subjects Trial (Recombinant Humanized Anti-PD-1 Monoclonal Antibody Solution for Injection, Pembrolizumab

Not yet recruiting
  • Healthy Male Subjects
  • Recombinant Humanized Anti-PD-1 Monoclonal Antibody Solution for Injection
  • Pembrolizumab injection
  • (no location specified)
Oct 30, 2023

Classical Hodgkin Lymphoma, Relapsed Cancer, Refractory Cancer Trial in Toronto (Pembrolizumab, Bendamustine Hydrochloride)

Recruiting
  • Classical Hodgkin Lymphoma
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Dec 31, 2021

MSI-H Colorectal Cancer Trial in Pittsburgh (Regorafenib, Pembrolizumab)

Not yet recruiting
  • MSI-H Colorectal Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Aug 17, 2023

Hepatocellular Carcinoma Trial (Pembrolizumab)

Active, not recruiting
Has Results
  • Hepatocellular Carcinoma
  • Pembrolizumab
  • (no location specified)
Dec 15, 2022

HNSCC Trial (Danvatirsen, Pembrolizumab)

Not yet recruiting
  • HNSCC
  • (no location specified)
Apr 3, 2023

Solid Tumor, Cutaneous Squamous Cell Carcinoma, Endometrial Cancer Trial (favezelimab/pembrolizumab, pembrolizumab, lenvatinib)

Not yet recruiting
  • Solid Tumor
  • +2 more
  • favezelimab/pembrolizumab
  • +2 more
  • (no location specified)
Sep 7, 2023

Advanced Solid Tumors Trial (AMG 355, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Nov 9, 2023

Triple Negative Breast Tumors Trial (Pembrolizumab injection, Capecitabine tablets, Local radiotherapy)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Pembrolizumab injection
  • +2 more
  • (no location specified)
Jul 25, 2023

Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)

Not yet recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    SKCCC Johns Hopkins
Aug 16, 2023

Biliary Tract Cancer Trial (GEN-001, Pembrolizumab, mFOLFOX)

Not yet recruiting
  • Biliary Tract Cancer
  • (no location specified)
Aug 16, 2023

NSCLC, Renal Cell Carcinoma, Melanoma Trial (Pembrolizumab co-formulated with hyaluronidase, Pembrolizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Pembrolizumab co-formulated with hyaluronidase
  • Pembrolizumab
  • (no location specified)
Oct 19, 2023

Advanced Melanoma Trial in Pittsburgh (Pembrolizumab Injection [Keytruda], Metformin)

Recruiting
  • Advanced Melanoma
  • Pittsburgh, Pennsylvania
    Univ of Pittsburgh Medical Center Hillman Cancer Center
Jan 24, 2022

Kidney Cancer Trial in Tampa (Pembrolizumab, Interleukin-2)

Active, not recruiting
Has Results
  • Kidney Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 21, 2022

Melanoma Trial (V940, Pembrolizumab, Placebo)

Not yet recruiting
  • Melanoma
  • V940
  • +2 more
  • (no location specified)
Jul 12, 2023

NSCLC Trial (V940, Pembrolizumab, Placebo)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • V940
  • +2 more
  • (no location specified)
Oct 5, 2023

GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)

Recruiting
  • GastroEsophageal Cancer
  • Gastric Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Oct 25, 2023

Cancer, Solid Tumor, Melanoma Trial (KVA12123 - Dose Escalation, KVA12123 Plus Pembrolizumab - Dose Escalation, KVA12123 - Dose

Not yet recruiting
  • Cancer
  • +16 more
  • KVA12123 - Dose Escalation
  • +3 more
  • (no location specified)
Feb 2, 2023